My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

1.090 -0.440 (-28.76%)
Streaming Delayed Price Updated: 1:53 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,324,861
Open 1.200
Bid (Size) 1.080 (57)
Ask (Size) 1.090 (79)
Prev. Close 1.530
Today's Range 1.050 - 1.200
52wk Range 0.7749 - 3.392
Shares Outstanding 17,559,179
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million. 
Via Benzinga
Which stocks are experiencing notable movement on Friday?
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill

Performance

YTD
-52.6%
-52.6%
1 Month
+17.3%
+17.3%
3 Month
+26.8%
+26.8%
6 Month
-37.7%
-37.7%
1 Year
-65.1%
-65.1%

More News

Read More
Friday's session: gap up and gap down stocks
Via Chartmill
Lexaria Attending BIO International Convention
Via ACCESS Newswire
Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot
Via Benzinga
Topics Economy Stocks
What's going on in today's pre-market session
Via Chartmill
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Topics Artificial Intelligence
Why Are Lexaria Bioscience Shares Soaring 45% After Hours?
Via Benzinga
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
Via ACCESS Newswire
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
Via ACCESS Newswire
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
Via ACCESS Newswire
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
Via ACCESS Newswire
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
Via ACCESS Newswire
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
Via ACCESS Newswire
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
Via ACCESS Newswire
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 1.090
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 09/26/25 01:53 PM ET
What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
The market capitalization of Lexaria Bioscience Corp. - Common Stock is 19.14M
How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
Lexaria Bioscience Corp. - Common Stock has 19M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.